Biocompatibility Parameters with Standard and Increased Dose of Citrate in Hemodialysis-A Randomized Trial.

J Clin Med · 2021 · PMC8268353 · PMID 34279471

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although our previous in-vitro data showed a trend towards lower complement activation at higher doses of citrate [ 17 ], the results of the present clinical study confirm that no significant activation of complement occurs during RCA even at the standard dose.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.